{"id":"W2923956055","doi":"10.1016/j.cgh.2019.03.030","title":"Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases","year":2019,"lang":"en","type":"letter","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation","keywords":"Medicine; Vedolizumab; Infliximab; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Maintenance therapy; Discontinuation; Hepatology; Gastroenterology; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008002533,0.0001916792,0.0005990406,0.0003068559,0.001173337,0.001452555,0.0005738616,0.01013967,0.007702806],"category_scores_gemma":[0.007385543,0.0001905038,0.0006265252,0.0003811816,0.0008910996,0.0008586837,0.0004945646,0.007150781,0.002290748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001843422,"about_ca_system_score_gemma":0.001748323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001683839,"about_ca_topic_score_gemma":0.005042059,"domain_scores_codex":[0.9993392,0.0002683273,0.00007615552,0.00006116812,0.0001112367,0.00014396],"domain_scores_gemma":[0.9965308,0.001848401,0.0002744106,0.00008567918,0.000229534,0.00103119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.003537866,0.0005109788,0.02401172,0.0002420826,0.0001259464,0.02643472,0.0002703974,0.0004478965,0.001473185,0.004494629,0.806397,0.1320536],"study_design_scores_gemma":[0.004203883,0.00257988,0.05107854,0.001644947,0.0003965803,0.0607699,0.001788715,0.003448731,0.002157794,0.02643484,0.8453063,0.00018983],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02043918,0.008367354,0.0003246503,0.9347105,0.01227678,0.00002864102,0.0001294572,0.00007235201,0.02365116],"genre_scores_gemma":[0.1828227,0.0073861,0.001046214,0.7148682,0.08342374,0.00006714206,0.0001624222,0.00006723799,0.01015621],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01013967,"threshold_uncertainty_score":0.0257684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009068450563827471,"score_gpt":0.2531239845422343,"score_spread":0.2440555339784068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}